Epidemiology and natural history of hepatitis B

Brian J McMahon1

  • 1Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA. bdm9@cdc.gov

Insights

Hepatitis B virus (HBV) infection affects millions globally, posing a lifelong risk for liver cancer and cirrhosis. Early detection and regular monitoring are crucial for managing chronic HBV and preventing severe liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis B virus (HBV) infects 400 million worldwide, causing chronic infections with lifelong risks of cirrhosis and hepatocellular carcinoma (HCC).
  • Many infected individuals are unaware of their status, and few receive regular monitoring for disease progression.
  • High-risk populations, including immigrants from endemic regions, require targeted screening and vaccination strategies.

Purpose of the Study:

  • To highlight the global burden of Hepatitis B virus (HBV) infection.
  • To emphasize the importance of screening, vaccination, and monitoring for chronic HBV.
  • To discuss factors influencing HBV natural history and the role of antiviral therapy.

Main Methods:

  • Review of current epidemiological data on HBV prevalence and chronic infection.
  • Analysis of factors influencing the natural history of chronic HBV infection.
  • Evaluation of recent findings on antiviral therapy efficacy and the necessity of lifelong monitoring.

Main Results:

  • Chronic HBV infection presents a significant global health challenge with substantial risks of severe liver disease.
  • Disease progression is multifactorial, influenced by viral, host, and environmental elements.
  • Antiviral therapies show promise in reducing complications for selected patients, underscoring the need for ongoing management.

Conclusions:

  • Lifelong monitoring for active liver disease and HCC is essential for individuals with chronic HBV infection.
  • Targeted screening and vaccination in high-risk groups are critical public health interventions.
  • Understanding the dynamic nature of HBV and the impact of therapy informs clinical management strategies.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...